Joint National Laboratory for Antibody Drug Engineering, Henan University School of Basic Medical Sciences , Kaifeng, Henan , China.
Department of Cellular Biology and Anatomy, Medical College of Georgia at Augusta University and Charlie Norwood VA Medical Center , Augusta, Georgia.
Am J Physiol Cell Physiol. 2019 Jan 1;316(1):C81-C91. doi: 10.1152/ajpcell.00251.2018. Epub 2018 Nov 7.
RNA-induced silencing complex (RISC) is formed during RNA interference (RNAi), whereas stress granules (SG) are assembled in response to cellular stress. Here, we demonstrate an interesting connection between RISC and SG that may involve argonaute 2 (Ago2), a core component of RISC. We analyzed SG induction by arsenite, the commonly used SG inducer. SG formation was suppressed in heat shock transcription factor 1 (Hsf1) or hypoxia-inducible factor-1α (Hif1α) shRNA-transfected cells but not in Hsf1 or Hif1α-knockout cells, suggesting that RNAi per se (rather than gene deficiency) may account for the suppressive effect on SG. In support, the suppressive effect of RNAi on SG formation was reversed by the RISC-loading inhibitor aurintricarboxylic acid. In non-RNAi cells, arsenite induced the accumulation of Ago2 in SGs as shown by its colocalization and coimmunoprecipitation with SG proteins, but Ago2 was not recruited to SG in the cells with RNAi. Consistently, arsenite induced the dissociation of Ago2 from RISC proteins in non-RNAi cells but not in RNAi cells. CRISPR-Cas9-medicated ablation of Ago2 attenuated SG formation during arsenite treatment, suggesting a critical role of Ago2 in SG assembly. Together, these results indicate that RISC and SG may compete for some key components, such as Ago2. In response to cellular stress, Ago2 is recruited for SG assembly; however, during RNAi, Ago2 is held in RISC, becoming unavailable for SG formation.
RNA 诱导沉默复合物 (RISC) 在 RNA 干扰 (RNAi) 期间形成,而应激颗粒 (SG) 则响应细胞应激而组装。在这里,我们展示了 RISC 和 SG 之间的有趣联系,这可能涉及 RISC 的核心组成部分 Argonaute 2 (Ago2)。我们分析了亚砷酸盐诱导的 SG 诱导,亚砷酸盐是常用的 SG 诱导剂。在热休克转录因子 1 (Hsf1) 或低氧诱导因子-1α (Hif1α) shRNA 转染的细胞中,SG 的形成受到抑制,但在 Hsf1 或 Hif1α 敲除的细胞中未受到抑制,这表明 RNAi 本身(而不是基因缺失)可能导致 SG 形成的抑制作用。支持这一观点的是,RISC 加载抑制剂金精三羧酸逆转了 RNAi 对 SG 形成的抑制作用。在非 RNAi 细胞中,亚砷酸盐诱导 Ago2 在 SG 中的积累,如与 SG 蛋白的共定位和共免疫沉淀所示,但在具有 RNAi 的细胞中,Ago2 未被招募到 SG 中。一致地,亚砷酸盐诱导 Ago2 从非 RNAi 细胞中的 RISC 蛋白解离,但不在 RNAi 细胞中。CRISPR-Cas9 介导的 Ago2 消融减弱了亚砷酸盐处理过程中的 SG 形成,表明 Ago2 在 SG 组装中起关键作用。总之,这些结果表明 RISC 和 SG 可能竞争一些关键成分,如 Ago2。在细胞应激时,Ago2 被招募用于 SG 组装;然而,在 RNAi 期间,Ago2 被保留在 RISC 中,无法用于 SG 形成。